Patient Radiation Dosage During Lower Extremity Endovascular Intervention.
Aged
Aged, 80 and over
Endovascular Procedures
/ adverse effects
Female
Humans
Lower Extremity
/ blood supply
Male
Middle Aged
Operative Time
Peripheral Arterial Disease
/ diagnostic imaging
Radiation Dosage
Radiation Exposure
/ adverse effects
Radiation Injuries
/ etiology
Radiography, Interventional
/ adverse effects
Registries
Retrospective Studies
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome
United States
peripheral vascular intervention
radiation
Journal
JACC. Cardiovascular interventions
ISSN: 1876-7605
Titre abrégé: JACC Cardiovasc Interv
Pays: United States
ID NLM: 101467004
Informations de publication
Date de publication:
11 03 2019
11 03 2019
Historique:
received:
18
09
2018
revised:
22
10
2018
accepted:
06
11
2018
entrez:
9
3
2019
pubmed:
9
3
2019
medline:
6
5
2020
Statut:
ppublish
Résumé
The aims of this study were to determine the incidence of actionably high radiation dosages and to identify predictors of increased patient dosage. Peripheral endovascular intervention using fluoroscopic imaging has become a mainstay of treatment for lower extremity peripheral artery disease but exposes patients to ionizing radiation. Patient radiation dosage, quantified as dose-area product (DAP), was obtained from the National Cardiovascular Data Registry Peripheral Vascular Intervention Registry. The percentage of procedures exceeding a DAP of 500 Gy · cm Among 17,174 procedures performed at 73 sites, patient DAP exceeded 500 Gy · cm Radiation dosage with the potential for tissue injury occurs in 1 of every 14 patients undergoing lower extremity endovascular interventions, and all such patients are exposed to the potential for subsequent malignancy. Pre-procedural assessment of patients' risk for elevated radiation dosage may allow targeted use of radiation mitigation strategies in patients at increased risk for elevated exposure.
Sections du résumé
OBJECTIVES
The aims of this study were to determine the incidence of actionably high radiation dosages and to identify predictors of increased patient dosage.
BACKGROUND
Peripheral endovascular intervention using fluoroscopic imaging has become a mainstay of treatment for lower extremity peripheral artery disease but exposes patients to ionizing radiation.
METHODS
Patient radiation dosage, quantified as dose-area product (DAP), was obtained from the National Cardiovascular Data Registry Peripheral Vascular Intervention Registry. The percentage of procedures exceeding a DAP of 500 Gy · cm
RESULTS
Among 17,174 procedures performed at 73 sites, patient DAP exceeded 500 Gy · cm
CONCLUSIONS
Radiation dosage with the potential for tissue injury occurs in 1 of every 14 patients undergoing lower extremity endovascular interventions, and all such patients are exposed to the potential for subsequent malignancy. Pre-procedural assessment of patients' risk for elevated radiation dosage may allow targeted use of radiation mitigation strategies in patients at increased risk for elevated exposure.
Identifiants
pubmed: 30846087
pii: S1936-8798(18)32293-3
doi: 10.1016/j.jcin.2018.11.005
pii:
doi:
Types de publication
Journal Article
Multicenter Study
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
473-480Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.